Bioaffinity Technologies Inc.
13F holders, Q4 2025 (December 31)9holders −3
4new positions
7sold out
1famous investor
$1.18avg. 13F price*
At the end of Q4 2025, 9 institutions reported holding Bioaffinity Technologies Inc. in their 13F filings, down 3 from Q3 2025. 4 opened new positions and 7 sold out. The largest holders were Geode Capital Management, LLC ($36K), Northern Trust Corp. ($15K) and Citadel Advisors ($14K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Bioaffinity Technologies Inc.
- CUSIP
- 09076W307
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $78K |
| Exits | 7 | $804K |
All 13F filers, Q3 2025 → Q4 2025: 74,974 shares bought and 273,408 shares sold, net −198,434 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Geode Capital Management, LLC | 0.00% | New | 30,422 | $36K |
| Northern Trust Corp. | 0.00% | New | 12,725 | $15K |
| Citadel Advisors | 0.00% | New | 11,631 | $14K |
| Two Sigma Securities, LLC | 0.00% | New | 11,125 | $13K |
| Citigroup Inc. | 0.00% | Add +10221.3% | 7,741 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +56.2% | 3,904 | $5K |
| IFP Advisors, Inc | 0.00% | No change | 833 | $983 |
| Bank of America Corp. | 0.00% | Reduce -97.7% | 38 | $45 |
| Morgan Stanley | 0.00% | No change | 3 | $4 |
"% of holder's portfolio" is BIOAFFINITY TECHNOLOGIES INC's weight in each manager's 13F, not the share of Bioaffinity Technologies Inc. the manager owns.